Category: axin2 antibody

UCP1 expression in the mouse adrenal gland is not upregulated by thermogenic conditions
NOX1/NADPH oxidase is involved in the LPS-induced exacerbation of collagen-induced arthritis
Covalent linkage of sulfated hyaluronan to the collagen scaffold Mucograft® enhances scaffold stability and reduces proinflammatory macrophage activation in vivo

Covalent linkage of sulfated hyaluronan to the collagen scaffold Mucograft® enhances scaffold stability and reduces proinflammatory macrophage activation in vivoCovalent linkage of sulfated hyaluronan to the collagen scaffold Mucograft® enhances scaffold stability and reduces proinflammatory macrophage activation in vivo

Sulfated glycosaminoglycans (sGAG) present interplay with organic mediator proteins. Though collagen-based biomaterials are broadly utilized in clinics, their mixture with high-sulfated hyaluronan is unexplored. This research goals to functionalize a

Role of Nampt overexpression in a rat model of Hashimoto's thyroiditis and its mechanism of action.
Prenatal indole-3-carbinol administration activates aryl hydrocarbon receptor-responsive genes and attenuates lung injury in a bronchopulmonary dysplasia model

Prenatal indole-3-carbinol administration activates aryl hydrocarbon receptor-responsive genes and attenuates lung injury in a bronchopulmonary dysplasia modelPrenatal indole-3-carbinol administration activates aryl hydrocarbon receptor-responsive genes and attenuates lung injury in a bronchopulmonary dysplasia model

Hyperoxia-hypoxia publicity is a proposed reason behind alveolar developmental arrest in bronchopulmonary dysplasia in preterm infants, the place mitochondrial reactive oxygen species and oxidative stress vulnerability are elevated. The aryl

Trichuris muris infection drives cell-intrinsic IL4R alpha independent colonic RELMα+ macrophages
Chimeric Antigen Receptor-T Cells: A Pharmaceutical Scope
Immune inactivation of anti-simian immunodeficiency virus chimeric antigen receptor T cells in rhesus macaques
Development and Validation of a Good Manufacturing Process for IL-4-Driven Expansion of Chimeric Cytokine Receptor-Expressing CAR T-Cells

Development and Validation of a Good Manufacturing Process for IL-4-Driven Expansion of Chimeric Cytokine Receptor-Expressing CAR T-CellsDevelopment and Validation of a Good Manufacturing Process for IL-4-Driven Expansion of Chimeric Cytokine Receptor-Expressing CAR T-Cells

Adoptive most cancers immunotherapy utilizing chimeric antigen receptor (CAR) engineered T-cells holds nice promise, though a number of obstacles hinder the environment friendly technology of cell merchandise beneath good manufacturing